Amanote Research
Register
Sign In
New PrEP Formulation Approved…but Only for Some
The Lancet HIV
- United Kingdom
doi 10.1016/s2352-3018(19)30350-9
Full Text
Open PDF
Abstract
Available in
full text
Categories
Epidemiology
Infectious Diseases
Immunology
Virology
Date
November 1, 2019
Authors
Unknown
Publisher
Elsevier BV
Related search
PrEP Works, but Only When You [Have Access To] Take It: Improving PrEP Access for Young People in Chicago and Philadelphia
International Journal of Virology and AIDS
Avastin Approved for Some Cervical Cancers
Cancer Discovery
Oncology
Enasidenib Approved for AML, but Best Uses Unclear
Cancer Discovery
Oncology
HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial
Trends in Urology & Men's Health
The Socio-Technical Connection Is Plastic, but Only When Design Starts From Need Formulation
New & Approved: New Approvals, Indications, Formulations
Pharmacy Today
Current Concepts for PrEP Adherence in the PrEP Revolution
Current Opinion in HIV and AIDS
Virology
Oncology
Infectious Diseases
Immunology
Hematology
Some Guppies Only Have Eyes for Orange
Journal of Experimental Biology
Evolution
Ecology
Insect Science
Molecular Biology
Systematics
Animal Science
Medicine
Aquatic Science
Behavior
Zoology
Physiology
Success Coming — But Only Slowly
Nature
Multidisciplinary